Clinical Trials Browser

Phase 2 × Interventional × Urologic Neoplasms × Clear all

NCT02675829 2026-03-04

Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers

Phase 2 Active not recruiting

GenitourinaryThoracic

Urinary Bladder Neoplasms, Lung Neoplasms, Urologic Neoplasms

NCT03541902 2026-01-09

Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma

Phase 2 Active not recruiting

Carcinoma, Renal Cell, Urologic Neoplasms

NCT06680089 2025-12-31

CD70-targeted immunoPET Imaging of Kidney Cancer

Phase 2 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasms, Urogenital Neoplasms, Urologic Neoplasms

NCT04579380 2025-12-19

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Phase 2 Active not recruiting

217 enrolled 19 charts

BreastGastrointestinalGenitourinaryGynecologicThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Urologic Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

NCT06353906 2025-12-08

PRIAM

Phase 2 Recruiting

Penile Neoplasms, Urogenital Neoplasms, Urologic Neoplasms, Male Urogenital Diseases

NCT05935748 2025-11-12

Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)

Phase 2 Terminated

Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT05169437 2025-10-29

PAVO

Phase 2 Terminated

22 enrolled 17 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Urologic Neoplasms, Endometrial Neoplasms

NCT05241340 2025-10-24

RAD-VACCINE

Phase 2 Active not recruiting

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT05785039 2025-09-26

A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Locally Advanced or Metastatic Urinary System Tumors

Phase 2 Recruiting

Urologic Neoplasms

NCT06237920 2025-09-03

TURANDORELA

Phase 2 Recruiting

Urogenital Diseases, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Urologic Neoplasms, Female Urogenital Diseases, Male Urogenital Diseases

NCT03219333 2024-08-27

EV-201

Phase 2 Completed

219 enrolled 32 charts 4 FDA

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms, Urologic Neoplasms

NCT06427057 2024-05-23

A Study of Cadonilimab（AK104）Combined With Standard Treatment for Function Preservation in Urinary System Tumors

Phase 2 Not yet recruiting

Urologic Neoplasms

NCT03339843 2024-03-15

MiMe-A

Phase 2 Completed

GastrointestinalGenitourinaryGynecologic

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Neoplasms, Urologic Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT00019396 2024-03-04

flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer

Phase 2 Completed

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma, Neoplasms, Skin Neoplasms, Urologic Neoplasms

NCT00019539 2024-03-04

Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell, Neoplasms, Urologic Neoplasms

NCT04931979 2023-03-01

Pembro-SRT

Phase 2 Unknown

Urologic Neoplasms

NCT05038657 2022-10-03

AURORA

Phase 2 Unknown

Carcinoma, Squamous Cell, Urologic Neoplasms

NCT04784507 2022-04-12

En-Bloc Resection of Bladder Tumors

Phase 2 Unknown

Urinary Bladder Neoplasms, Urogenital Neoplasms, Urologic Neoplasms

NCT04644432 2020-11-25

INDIGO

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms, Urogenital Neoplasms, Urologic Neoplasms

NCT02780687 2020-11-18

LUX-Bladder 1

Phase 2 Completed

42 enrolled 16 charts

Urologic Neoplasms

NCT00226954 2020-03-18

Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer

Phase 2 Terminated

Urologic Neoplasms

NCT02307487 2017-06-16

Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients

Phase 2 Completed

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT00350025 2017-03-31

Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer

Phase 2 Completed

41 enrolled 11 charts

Neoplasm Metastasis, Neoplasms, Urologic Neoplasms

NCT01454089 2016-10-07

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urologic Neoplasms

NCT01599013 2015-12-08

JASINT1

Phase 2 Completed

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasm Metastasis, Urogenital Neoplasms, Urologic Neoplasms, Renal Insufficiency

NCT02006667 2015-02-11

A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer

Phase 2 Completed

13 enrolled 12 charts

Urologic Neoplasms

NCT00151034 2015-01-21

Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer

Phase 2 Completed

Urologic Neoplasms

NCT02013765 2014-09-25

A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer

Phase 2 Terminated

5 enrolled 12 charts

Urologic Neoplasms

NCT00034177 2009-06-04

Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium

Phase 2 Completed

Neoplasm Metastasis, Urologic Neoplasms

NCT00191971 2007-11-06

2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen

Phase 2 Completed

Carcinoma, Transitional Cell, Urologic Neoplasms

NCT00134186 2007-03-05

Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer

Phase 2 Completed

Carcinoma, Renal Cell, Kidney Neoplasms, Urogenital Neoplasms, Urologic Neoplasms

NCT00294476 2006-10-12

IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma

Phase 2 Unknown

DermatologicGastrointestinalGenitourinary

Colonic Neoplasms, Melanoma, Neoplasms, Urologic Neoplasms

NCT00034593 2006-07-19

A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Phase 2 Completed

Urinary Bladder Neoplasms, Neoplasm Metastasis, Urologic Neoplasms

NCT00035061 2006-07-19

A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium

Phase 2 Completed

Urinary Bladder Neoplasms, Neoplasm Metastasis, Recurrence, Urologic Neoplasms